ArticleMolecular genetics and genomics : MGG2026
An enhanced transformer model for detecting 1p36 deletion syndrome.
Article in Molecular genetics and genomics : MGG, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The most prevalent terminal chromosomal deletion disorder, chromosome 1p36 deletion syndrome, leads to developmental delays and intellectual disabilities and seizures and heart defects and distinct facial appearance. Traditional cytogenetic methods, which include karyotyping, face difficulties in early detection of these abnormalities because it require extensive work and substantial time and it can only identify major genetic changes, which makes it unsuitable for detecting minor genomic alterations that occur during infancy. The field of Deep Learning (DL) has made progress toward improving genomic data analysis and disease-related gene identification since its introduction. Hence, the MultiSight Transformer functions as a proposed framework, which processes gene sequences through its multi-head self-attention mechanism to study 1p36 chromosome 1 deletion effects. The model used training and testing procedures on combined datasets which included genomic variations from chromosome 1 and 1p36 deletion regions that contained copy number variations linked to clinical symptoms of skeletal and gastrointestinal and cardiac and chronic kidney disease. The proposed method enables effective gene sequence classification and prediction of the contribution of 1p36 deletion syndrome to major clinical conditions. The experimental results show that the model reaches an accuracy of 0.97 and a precision of 0.90 and a recall of 0.9195 and an F1-score of 0.90 and an area under the curve (AUC) of 0.94 which demonstrates its strong predictive performance. The findings demonstrate that researchers can enhance the detection accuracy and efficiency of chromosome 1p36 deletion syndrome through the combination of transformer-based deep learning models with genomic data analysis. The findings 1p36 deletion detection research should support early diagnosis and clinical decision-making activities.
Indexed as
Identifiers
41917487What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.